122 related articles for article (PubMed ID: 34639688)
1. CoCoss-Trial: Concurrent Comparison of Self-Sampling Devices for HPV-Detection.
Ertik FC; Kampers J; Hülse F; Stolte C; Böhmer G; Hillemanns P; Jentschke M
Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639688
[TBL] [Abstract][Full Text] [Related]
2. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections.
Jentschke M; Chen K; Arbyn M; Hertel B; Noskowicz M; Soergel P; Hillemanns P
J Clin Virol; 2016 Sep; 82():46-50. PubMed ID: 27434147
[TBL] [Abstract][Full Text] [Related]
4. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
5. Clinical Performance of the RealTi
Latsuzbaia A; Vanden Broeck D; Van Keer S; Weyers S; Tjalma WAA; Doyen J; Donders G; De Sutter P; Vorsters A; Peeters E; Arbyn M
Microbiol Spectr; 2022 Oct; 10(5):e0163122. PubMed ID: 36047900
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study.
Ørnskov D; Jochumsen K; Steiner PH; Grunnet IM; Lykkebo AW; Waldstrøm M
BMJ Open; 2021 Mar; 11(3):e041512. PubMed ID: 33674367
[TBL] [Abstract][Full Text] [Related]
7. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
9. Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
Leinonen MK; Schee K; Jonassen CM; Lie AK; Nystrand CF; Rangberg A; Furre IE; Johansson MJ; Tropé A; Sjøborg KD; Castle PE; Nygård M
J Clin Virol; 2018; 99-100():22-30. PubMed ID: 29289814
[TBL] [Abstract][Full Text] [Related]
10. Performance of a six-methylation-marker assay on self-collected cervical samples - A feasibility study.
Klischke L; von Ehr J; Kohls F; Kampers J; Hülse F; Schmitz M; Hennig A; Dörk T; Hillemanns P; Jentschke M
J Virol Methods; 2021 Sep; 295():114219. PubMed ID: 34175345
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.
Van Keer S; Latsuzbaia A; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Arbyn M; Vorsters A
J Clin Virol; 2022 Oct; 155():105271. PubMed ID: 36049283
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study.
Haguenoer K; Giraudeau B; Gaudy-Graffin C; de Pinieux I; Dubois F; Trignol-Viguier N; Viguier J; Marret H; Goudeau A
Gynecol Oncol; 2014 Aug; 134(2):302-8. PubMed ID: 24905772
[TBL] [Abstract][Full Text] [Related]
13. Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
Martinelli M; Latsuzbaia A; Bonde J; Pedersen H; Iacobone AD; Bottari F; Piana AF; Pietri R; Cocuzza CE; Arbyn M;
Microbiol Spectr; 2024 Mar; 12(3):e0287223. PubMed ID: 38323823
[TBL] [Abstract][Full Text] [Related]
14. Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests.
Aranda Flores CE; Gomez Gutierrez G; Ortiz Leon JM; Cruz Rodriguez D; Sørbye SW
BMC Infect Dis; 2021 May; 21(1):504. PubMed ID: 34058992
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
16. Excellent analytical and clinical performance of a dry self-sampling device for human papillomavirus detection in an urban Chinese referral population.
Chen K; Ouyang Y; Hillemanns P; Jentschke M
J Obstet Gynaecol Res; 2016 Dec; 42(12):1839-1845. PubMed ID: 27647799
[TBL] [Abstract][Full Text] [Related]
17. Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial.
Davies JC; Sargent A; Pinggera E; Carter S; Gilham C; Sasieni P; Crosbie EJ
BJOG; 2024 Apr; ():. PubMed ID: 38660737
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of self-sampling-based cervical cancer screening strategy using HPV Selfy CE-IVD test coupled with home-collection kit: a clinical study in Italy.
Feltri G; Valenti G; Isidoro E; Kaur J; Treleani M; Bartelloni A; Mauro C; Spiga F; Ticich G; Di Napoli M; Biagi C; Pachetti M; Centonze S; Castriciano S; Zanchiello S; Giudici F; Gerin D; Zanconati F
Eur J Med Res; 2023 Dec; 28(1):582. PubMed ID: 38072937
[TBL] [Abstract][Full Text] [Related]
19. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
Lefeuvre C; Pivert A; Guillou-Guillemette HL; Lunel-Fabiani F; Veillon P; Le Duc-Banaszuk AS; Ducancelle A
J Infect; 2020 Aug; 81(2):248-254. PubMed ID: 32413363
[TBL] [Abstract][Full Text] [Related]
20. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
Cox JT;
Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]